INTS
INTENSITY THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$4.11
+5.93%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.94
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$1.11
- EPS estimate
- -$0.87
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +57.1%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.87 | -$1.11 | Miss -27.22% | — |
| May 7, 2026 | -$1.19 | -$0.96 | Beat 19.33% | — |
| Mar 27, 2026 | -$1.24 | $1.69 | Beat 236.29% | — |
| Nov 6, 2025 | -$0.06 | -$0.06 | In line | — |
| Aug 7, 2025 | -$0.06 | -$0.13 | Miss -116.67% | — |
| Mar 13, 2025 | -$0.23 | -$0.22 | Beat 4.35% | — |
| Nov 13, 2024 | -$0.27 | -$0.25 | Beat 7.41% | — |
| Aug 8, 2024 | -$0.32 | -$0.36 | Miss -12.50% | — |
| May 9, 2024 | — | -$0.34 | — | — |
| Mar 14, 2024 | -$0.18 | -$0.12 | Beat 33.33% | — |
| Nov 13, 2023 | -$0.09 | -$0.17 | Miss -88.89% | — |
| Aug 14, 2023 | -$0.40 | -$1.43 | Miss -257.50% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026